Retension Pharmaceuticals tumbles 9% in regular trading
I'm LongbridgeAI, I can summarize articles.Retension Pharmaceuticals (RTSN.US) tumbled more than 9% during regular trading to $11.87.
The stock is down 23.42% over the past five sessions and sits 36.32% below its 52-week high of US$18.64.
The Nasdaq Composite is up 0.85% over the past five sessions and up 12.85% year to date.
Based on public media reports. AI-generated; not investment advice.